Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
boston top stories
clinical trials
fda
boston
san francisco blog main
biotech ipos
cancer
deals
investing
ipo
medical device
national
national top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
rare disease drugs
san diego blog main
san diego top stories
san francisco top stories
startups
480 biomedical
abbvie
accent therapeutics
actavalon
acute myeloid leukemia
aducanumab
aileron therapeutics
akouos
alzheimer's disease
amblyotech
aprea therapeutics
arimoclomol
arnold levine
arsenal medical
asklepios biopharmaceutical
What
developing
5
×
ipo
5
×
company
medicines
therapeutics
drug
fda
million
new
public
raised
tests
treat
activity
affects
americans
approvals
approved
bio
biogen
biotech
blood
brings
broader
cancer
clamped
covid
date
debut
delays
detect
disorders
dyne
dyne’s
economic
fast
files
firms
frequency
genetic
Language
unset
Current search:
xconomy.com
×
developing
×
ipo
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds